摘要
目的 :观察白龙片配合化疗治疗气血两虚型中晚期肺癌患者的临床疗效。方法 :按实体瘤治疗标准进行疗效分析 ,评定其改善症状、生活质量及免疫功能的变化。结果 :治疗组 30例患者症状改善率为 96 .6 % ,病灶缓解率 11.76 % ,生活质量改善 ,机体免疫力增强 ,治疗后与对照组比较均有显著性差异 (P <0 .0 1)。结论 :白龙片对中晚期肺癌化疗患者有较肯定疗效 ,其抗癌作用与免疫功能增强 ,如NK细胞和IL
Objective: To observe the clinical effect of Bailong Tablets combined with chemotherapy on NSCLC(dual vacuity of qi and blood syndrome). Methods: According to the clinical effect standard of solid tumour, the curative effects were analyzed and the changes in improvement of symptons、 immunity and life quality were evaluated.Results: In the treatment group(30 cases), improvement rate of sympton was 99.6%. The focal remission rate was 11.76%. The life quality was improved and immunologic function was strengthened. There were significant differences between the treatment group and the control group ( P <0.01).Conclusion: Bailong Tablets combined with chemotherapy had a confirmed clinical effect on the intermediate and late NSCLC. Its antitumor and immunologic actions are increased, such as the raising of activities of NK cell and IL 2.
出处
《中成药》
CAS
CSCD
北大核心
2001年第3期191-193,共3页
Chinese Traditional Patent Medicine